05:31 PM EDT, 08/28/2024 (MT Newswires) -- Qiagen ( QGEN ) said late Wednesday it is expanding its master collaboration agreement with AstraZeneca ( AZN ) .

Qiagen ( QGEN ) will use its QIAstat-Dx syndromic testing platform to develop and validate a genotyping assay that will allow specialty care providers to potentially perform genotyping while patients are undergoing routine clinical examination, the company said.

Price: 45.81, Change: +0.02, Percent Change: +0.04